Amalgam Rx’s Medical-Grade AI™ Doubles Digital Health Engagement—Validated in Peer-Reviewed Studies.
Amalgam Rx, Inc., a leader in AI-powered healthcare decision-making, announced the publication of two peer-reviewed research papers validating its Medical‑Grade AI™ framework---a clinically governed system delivering safe and highly engaging digital experiences.
Amalgam Rx Named to the 2022 CB Insights’ Digital Health 150 List
CB Insights today named Amalgam Rx to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022.
Amalgam Rx™ and Novo Nordisk® Plan Global Expansion
Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing global expansion of its insulin titration solution with Novo Nordisk. Initially, the companies successfully commercialized Dose Check, a white-labeled version of iSage RxTM, in select countries in South America. Now, with Amalgam’s recently received CE Mark for iSage Rx and Dose Check, Novo Nordisk is planning a global expansion. In 2021, Dose Check will launch in multiple countries in Europe and Asia.
